Barmherzige Brueder gemeinnuetzige Traeger GmbH — Clinical Trial Site

9 Registered trials

6 Currently recruiting

Organisation

Barmherzige Brueder gemeinnuetzige Traeger GmbH

Location

Straubing, Germany

Identifier

ORG-100047406

Address

St.-Elisabeth-Str. 23, 94315, Germany

Departments

Abteilung für Urologie
Hematology and Internal Oncology
II. Medizinische Klinik, Innere Medizin
Klinik fuer Hals-Nasen-Ohrenheilkunde, Kopf-Hals- und plastische Gesichtschirurgie
Klinik für Hals-Nasen-Ohren-Heilkunde
Klinikum St. Elisabeth Straubing GmbH
MVZ Barmherzige Brüder Straubing
Rheumatology
Urology

Clinical trials at this site (9)

Search interface

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB 3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Pre… Recruiting

2025-524366-21-00 treatment-naive Chronic Lymphocytic Leukemia 5 2026-04-29
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Randomized phase III trial of sequential Re-Radiochemotherapy and Pembrolizumab versus Immuno(chemo)therapy for locoregionally recurrent PD-… Recruiting

2024-520264-33-00 Locoregionally recurrent head and neck squamous cell ca 5 2025-10-07
A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt… Recruiting

2023-507684-19-00 FGFR+ Intermediate-risk Non-muscle Invasive Bladder Can 5 2024-07-24
A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Un… Recruiting

2023-508613-17-00 Neoplasms, Head and Neck 5 2024-05-29
Safety and immunologic response of SHIngrix VAccination in patients suffering from Psoriasis or Psoriatic arthritis Recruiting

2024-512881-32-00 Psoriasis vulgaris and/or psoriatric arthritis 6 2023-11-22
A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 High-risk localized or locally advanced prostate cancer 5 2019-07-11
HU-F-AIM - A prospective, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet… Ended

2022-502338-20-00 Polycythemia vera 6 2023-07-28
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended

2024-512727-36-00 Patients with atrial fibrillation and ST-segment elevat 6 2021-12-21